Mozambique

in page functions
[French]
Mozambique
Total population (2017) 29,537,849
Birth cohort (2017) 1,122,799
Surviving Infants (surviving to 1 year per year, 2017) 1,058,346
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 79/1000
World Bank Index, IDA (2015) 3.48
Gross Nation Income (per capita US$, 2015) 590
Co-financing group (2017) Initial self-financing
No. of districts/territories (2016) 159

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Mozambique

Type of support

Approvals

2001-2021 (US$)
(23 Aug 2017)

Commitments

2001-2021 (US$)
(23 Aug 2017)

Disbursements

2000-2017 (US$)
(23 Aug 2017)

% Disbursed

(23 Aug 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $196,801,349 $212,236,603 $198,820,311
Cash Support (CASHSUPP) $170,000 $170,000 $170,000 100%
Health system strengthening (HSS 1) $15,465,013 $25,041,767 $7,110,931 46%
HPV Demo (NVS) $56,503 $56,503 $56,503 100%
Immunisation services support (ISS) $1,665,500 $1,665,500 $1,665,500 100%
Injection Safety Devices (NVS) $1,137,000 $1,206,500 $1,340,969 118%
Injection safety support (INS) $835,881 $835,881 $835,881 100%
IPV (NVS) $5,183,412 $5,183,412 $3,564,106 69%
Measles (NVS) $1,088,988 $1,501,988 $1,083,191 99%
MR 1st dose (NVS) $721,500 $1,325,500
MR-Catch-up campaign (NVS) $9,046,500 $9,046,500 $8,939,612 99%
MR-Catch-up campaign op.costs (OPC) $7,935,500 $7,935,500 $7,879,866 99%
Penta (NVS) $44,703,048 $44,703,048 $43,836,706 98%
Pneumo (NVS) $75,214,231 $75,214,231 $89,774,794 119%
Product Switch Grant (PSG) $292,000 $292,000 $271,286 93%
Rotavirus (NVS) $11,654,652 $16,426,652 $10,684,147 92%
Tetra DTP-HepB (NVS) $16,897,320 $16,897,320 $16,897,320 100%
Vaccine Introduction Grant (VIG) $4,734,301 $4,734,301 $4,709,499 99%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Mozambique DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 96%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2010) 76.20%
Household survey: DTP3 coverage for female (2010) 76.10%
Household survey: Last DTP3 survey (2010) 76%
% districts achieving > 80% DTP3 coverage (2016)
% districts achieving < 50% DTP3 coverage (2016)
MCV WHO/UNICEF estimates (2016) 91%

Breakdown of support

Non-vaccine support Vaccine support
11% 89%
$22,642,963 $176,177,348

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Mozambique

26 April 2017

Mozambique-Norway

Different places, different families, same life-saving journey: Norway Q&A on value of vaccines

After a Gavi slideshow underlines how mothers living world’s apart share the same views on childhood immunisation, Norway’s Foreign Affairs Minister and the Director-General of the Institute of Public Health talk about the value of vaccines.

25 April 2017

Different places, different families, same life-saving journey

Life in Mozambique and Norway: the importance of routine immunisation to two families.

12 November 2014

WPD2012

Record numbers of children protected against leading causes of pneumonia with Gavi support

“la Caixa” Foundation announces further €1m commitment to support pneumococcal vaccine

close icon

modal window here